Gustave Roussy, Cancer Campus, Grand Paris

This study tested whether adding two targeted drugs (trametinib and dabrafenib) could make radioactive iodine treatment work again for people with advanced thyroid cancer that had stopped responding to it. The trial involved 40 adults whose cancer had spread and had specific gene…

This early-stage study tested the safety of combining two cancer drugs—cetuximab and temsirolimus—in adults with advanced solid tumors that no longer respond to standard treatments. Researchers wanted to see if blocking two different cancer growth pathways at once might be more e…

This trial tested whether adding the drug rituximab to standard chemotherapy could help children and teenagers with a rare type of chest lymphoma. It involved 47 young patients aged 6 months to 18 years who had not yet received treatment. The main goal was to see if this combinat…

This study tested whether a new, advanced robotic surgery system could be used to remove head and neck tumors through the mouth. The goal was to see if this less invasive approach was possible and could help reduce the long-term side effects and impact on quality of life that oft…

This early-stage trial tested a new combination of two existing drugs—an immunotherapy (pembrolizumab) and a drug that blocks blood vessel growth (nintedanib)—in patients with various advanced solid tumors that had stopped responding to standard treatments. The main goal was to f…

This trial tested whether adding a targeted drug called rituximab to standard chemotherapy could improve survival for children and adolescents with high-risk B-cell lymphoma or leukemia. It involved 482 young patients aged 6 months to 18 years with advanced disease. The main goal…

This study tested two improvements for hospital wheelchair transport to make patients more comfortable. Researchers evaluated a new system that connects IV poles directly to wheelchairs to save time, and tested a new, softer wheelchair seat. They measured whether these changes re…

This study asked men with advanced prostate cancer which of two standard chemotherapy drugs they preferred after trying both. The goal was to understand which treatment patients found more tolerable based on side effects and quality of life. Researchers enrolled 195 men who had n…

This study looked at how chemotherapy affects brain function in adults who were treated for bone cancer as children or teenagers. Researchers followed 92 French survivors for over 10 years after treatment ended to measure memory, thinking skills, and daily challenges. The goal wa…

This study aimed to better understand the skin side effects that can happen when people take newer, targeted cancer drugs. Researchers closely observed 141 adult cancer patients who were starting these treatments, tracking their skin reactions through exams and photos. The goal w…